Pfizer
Enabling Pfizer’s data and analytics leaders to collaborate better with business partners
Tags
As companies seek to foster collaboration among data, digital, and technology experts and their business counterparts, they face a quandary. Technical specialists have deep expertise but may, due to the nature of their day-to-day work, find it difficult to engage, communicate and problem-solve with their business partners.
Pfizer has a business analytics and insights (BAI) function that serves its global businesses and therapeutic areas. Its team provides research, analytics and insights to help their partners understand emerging opportunities and inform critical decisions. BAI leaders saw an opportunity to level up team members' soft skills, to enable colleagues to engage proactively with the business, ask the right questions, and shape the work effectively. By so doing, BAI will be better able to contribute to Pfizer's strategy of becoming data-driven and delivering 25 new breakthrough therapies by 2025.
PA partnered with BAI to create an interactive, engaging learning and development program that levelled-up team member's soft skills and ability to engage with business partners to deliver impactful insights. PA provided curriculum design and development expertise, using agile principles to rapidly evolve existing curricula to meet business and learning objectives. This approach could be used by any organization seeking to empower its technical specialists to become better partners to the business, to achieve corporate goals more rapidly.
Together, we refreshed a 12-month curriculum with 17 sub-modules in just 12 weeks, leveraging best practices to ensure training would be effective, retained, and culturally appropriate.
The soft skills curriculum uses self-guided learning, manager instruction, and peer-to-peer coaching to increase learner engagement and retention. It is currently being rolled out to a team of 150+ employees in 20+ countries.
We saw an opportunity to level-up the BAI team's soft skills, to enable colleagues to engage proactively with the business, ask the right questions, and shape the work effectively. By so doing, BAI is better able to contribute to Pfizer’s strategy of becoming data-driven and delivering 25 new breakthrough therapies by 2025.”
Explore more
